These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10976274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P, Zamagni E, Cellini C, Parente R, Cangini D, Tacchetti P, Perrone G, Ceccolini M, Boni P, Tura S, Baccarani M, Cavo M.
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [Abstract] [Full Text] [Related]

  • 4. [Role of biochemical indices as metastatic markers in patients with prostatic cancer invading skeleton].
    Liubimova NV, Trapeznikova MF, Robins SP, Ognerubov SA, Kushlinskiĭ NE.
    Urologiia; 2000 May; (4):15-9. PubMed ID: 11186686
    [Abstract] [Full Text] [Related]

  • 5. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M, Takahashi S, Ogata E.
    Anticancer Res; 2003 May; 23(5b):4095-9. PubMed ID: 14666607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M, Bonneterre J, Hecquet B, Desoize B, Demaille A.
    Anticancer Res; 1991 May; 11(2):831-3. PubMed ID: 2064338
    [Abstract] [Full Text] [Related]

  • 11. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ, Mikulecký M, Bek V, Broulík P, Pacovský V.
    Neoplasma; 1989 May; 36(4):495-501. PubMed ID: 2770935
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
    Pectasides D, Farmakis D, Nikolaou M, Kanakis I, Kostopoulou V, Papaconstantinou I, Karamanos NK, Economopoulos T, Raptis SA.
    J Pharm Biomed Anal; 2005 Feb 07; 37(1):171-6. PubMed ID: 15664758
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
    Desoize B, Veiler V, Pourny C, Comoe L, Jardillier JC.
    Anticancer Res; 1989 Feb 07; 9(4):1105-9. PubMed ID: 2817792
    [Abstract] [Full Text] [Related]

  • 16. Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan.
    Nelson JB, Nabulsi AA, Vogelzang NJ, Breul J, Zonnenberg BA, Daliani DD, Schulman CC, Carducci MA.
    J Urol; 2003 Mar 07; 169(3):1143-9. PubMed ID: 12576870
    [Abstract] [Full Text] [Related]

  • 17. The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessment.
    Lüftner D, Günther S, Flath B, Müller C, Echteroff K, Mergenthaler HG, Wernecke KD, Possinger K.
    Anticancer Res; 1999 Mar 07; 19(4A):2537-44. PubMed ID: 10470191
    [Abstract] [Full Text] [Related]

  • 18. Markers of bone turnover do not predict bone metastases in breast cancer.
    Seibel MJ, Koeller M, Van der Velden B, Diel I.
    Clin Lab; 2002 Mar 07; 48(11-12):583-8. PubMed ID: 12465741
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.
    Coleman RE, Major P, Lipton A, Brown JE, Lee KA, Smith M, Saad F, Zheng M, Hei YJ, Seaman J, Cook R.
    J Clin Oncol; 2005 Aug 01; 23(22):4925-35. PubMed ID: 15983391
    [Abstract] [Full Text] [Related]

  • 20. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N, Ilić M, Ignjatović S, Aleksandra-Postić-Grujin.
    Clin Lab; 2002 Aug 01; 48(7-8):407-13. PubMed ID: 12146575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.